{
  "input": {
    "mode": "revise",
    "query": {
      "entity": "Arrhythmogenic Right Ventricular Cardiomyopathy",
      "relation": "indication"
    },
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_sotalol",
          "type": "Drug",
          "label": "Sotalol",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_amiodarone",
          "type": "Drug",
          "label": "Amiodarone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_beta_blockers",
          "type": "Drug",
          "label": "Beta-blockers",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_dronedarone",
          "type": "Drug",
          "label": "Dronedarone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_verapamil",
          "type": "Drug",
          "label": "Verapamil",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_disopyramide",
          "type": "Drug",
          "label": "Disopyramide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_flecainide",
          "type": "Drug",
          "label": "Flecainide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_procainamide",
          "type": "Drug",
          "label": "Procainamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_digoxin",
          "type": "Drug",
          "label": "Digoxin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_lisinopril",
          "type": "Drug",
          "label": "Lisinopril",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_spironolactone",
          "type": "Drug",
          "label": "Spironolactone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_hydrochlorothiazide",
          "type": "Drug",
          "label": "Hydrochlorothiazide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "Disease_ARVC",
          "type": "Disease",
          "label": "Arrhythmogenic Right Ventricular Cardiomyopathy",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "Target_Beta_adrenergic_receptor",
          "type": "Target",
          "label": "Beta-adrenergic receptor",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "Pathway_Heart_regulation",
          "type": "Pathway",
          "label": "Heart rate and rhythm regulation",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "Phenotype_Arrhythmia",
          "type": "Phenotype",
          "label": "Arrhythmia",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "Phenotype_SV_Tachycardia",
          "type": "Phenotype",
          "label": "Supraventricular Tachycardia",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "Phenotype_Ventricular_Tachycardia",
          "type": "Phenotype",
          "label": "Ventricular Tachycardia",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_sotalol",
          "type": "Drug",
          "label": "Sotalol",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_amiodarone",
          "type": "Drug",
          "label": "Amiodarone",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_beta_blockers",
          "type": "Drug",
          "label": "Beta-blockers",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_dronedarone",
          "type": "Drug",
          "label": "Dronedarone",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_verapamil",
          "type": "Drug",
          "label": "Verapamil",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_disopyramide",
          "type": "Drug",
          "label": "Disopyramide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_flecainide",
          "type": "Drug",
          "label": "Flecainide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_procainamide",
          "type": "Drug",
          "label": "Procainamide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_digoxin",
          "type": "Drug",
          "label": "Digoxin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_lisinopril",
          "type": "Drug",
          "label": "Lisinopril",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_spironolactone",
          "type": "Drug",
          "label": "Spironolactone",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_hydrochlorothiazide",
          "type": "Drug",
          "label": "Hydrochlorothiazide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ARVC",
          "type": "Condition",
          "label": "Arrhythmogenic Right Ventricular Cardiomyopathy",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_sotalol",
          "type": "Target",
          "label": "OffTargetSotalol",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_sotalol",
          "type": "Pathway",
          "label": "RiskPathwaySotalol",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_sotalol",
          "type": "Phenotype",
          "label": "AdverseEffectSotalol",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Sotalol",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Amiodarone",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Beta-blockers",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Dronedarone",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Verapamil",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Disopyramide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Flecainide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Procainamide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Digoxin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Lisinopril",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Spironolactone",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Hydrochlorothiazide",
          "attrs": {
            "agent": "PI"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_sotalol",
          "target": "Target_Beta_adrenergic_receptor",
          "relation": "acts_on",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "Sotalol 是β-拮抗剂，作用于β-肾上腺素受体"
        },
        {
          "source": "drug_amiodarone",
          "target": "Target_Beta_adrenergic_receptor",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Amiodarone 通过调节心脏电生理特性影响心率"
        },
        {
          "source": "drug_beta_blockers",
          "target": "Target_Beta_adrenergic_receptor",
          "relation": "acts_on",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "β-阻滞剂主要通过作用于β-肾上腺素受体来降低心搏频率"
        },
        {
          "source": "drug_dronedarone",
          "target": "Target_Beta_adrenergic_receptor",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Dronedarone 通过多种机制影响心率，包含对β-受体的作用"
        },
        {
          "source": "drug_verapamil",
          "target": "Target_Beta_adrenergic_receptor",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Verapamil 作为钙通道阻滞剂影响心脏节律"
        },
        {
          "source": "drug_disopyramide",
          "target": "Target_Beta_adrenergic_receptor",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Disopyramide 可干预心脏传导与节律"
        },
        {
          "source": "drug_flecainide",
          "target": "Target_Beta_adrenergic_receptor",
          "relation": "acts_on",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "Flecainide 可降低心脏传导速度"
        },
        {
          "source": "drug_procainamide",
          "target": "Target_Beta_adrenergic_receptor",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "Procainamide 可用于治疗心律失常"
        },
        {
          "source": "drug_digoxin",
          "target": "Target_Beta_adrenergic_receptor",
          "relation": "acts_on",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "Digoxin 可增强心脏收缩力并影响心律"
        },
        {
          "source": "drug_lisinopril",
          "target": "Target_Beta_adrenergic_receptor",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "Lisinopril 可通过改善心脏功能间接影响心律"
        },
        {
          "source": "drug_spironolactone",
          "target": "Target_Beta_adrenergic_receptor",
          "relation": "acts_on",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "Spironolactone 作为利尿剂有助于心脏病患者"
        },
        {
          "source": "drug_hydrochlorothiazide",
          "target": "Target_Beta_adrenergic_receptor",
          "relation": "acts_on",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "Hydrochlorothiazide 可用于减少心脏负担"
        },
        {
          "source": "Target_Beta_adrenergic_receptor",
          "target": "Pathway_Heart_regulation",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "β-肾上腺素受体在心脏调节通路中的核心作用"
        },
        {
          "source": "Pathway_Heart_regulation",
          "target": "Phenotype_Arrhythmia",
          "relation": "causes",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "心脏调节通路失调可导致心律失常"
        },
        {
          "source": "Pathway_Heart_regulation",
          "target": "Phenotype_SV_Tachycardia",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "心脏节律失调引起的超心速症"
        },
        {
          "source": "Pathway_Heart_regulation",
          "target": "Phenotype_Ventricular_Tachycardia",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "心脏电生理异常引起心室心动过速"
        },
        {
          "source": "drug_sotalol",
          "target": "Disease_ARVC",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Sotalol 用于治疗心律失常，适用于患者"
        },
        {
          "source": "drug_amiodarone",
          "target": "Disease_ARVC",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Amiodarone 能有效控制心律失常"
        },
        {
          "source": "drug_beta_blockers",
          "target": "Disease_ARVC",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "β-阻滞剂广泛应用于心律失常的管理"
        },
        {
          "source": "drug_dronedarone",
          "target": "Disease_ARVC",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Dronedarone 是心律靶向治疗的重要药物"
        },
        {
          "source": "drug_verapamil",
          "target": "Disease_ARVC",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "Verapamil 作为抗心律药物用途广泛"
        },
        {
          "source": "drug_disopyramide",
          "target": "Disease_ARVC",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "Disopyramide 可改善心率问题"
        },
        {
          "source": "drug_flecainide",
          "target": "Disease_ARVC",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "Flecainide 在某些心律失常中很有效"
        },
        {
          "source": "drug_procainamide",
          "target": "Disease_ARVC",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "Procainamide 在控制心律方面有效"
        },
        {
          "source": "drug_digoxin",
          "target": "Disease_ARVC",
          "relation": "supports",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "Digoxin 可能对控制心率有积极作用"
        },
        {
          "source": "drug_lisinopril",
          "target": "Disease_ARVC",
          "relation": "supports",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "Lisinopril 除心率外还改善心脏功能"
        },
        {
          "source": "drug_spironolactone",
          "target": "Disease_ARVC",
          "relation": "supports",
          "weight": 0.35,
          "agent": "Proponent",
          "rationale": "Spironolactone 可辅助性改善患者心脏功能"
        },
        {
          "source": "drug_hydrochlorothiazide",
          "target": "Disease_ARVC",
          "relation": "supports",
          "weight": 0.3,
          "agent": "Proponent",
          "rationale": "Hydrochlorothiazide 可减轻心脏负担"
        },
        {
          "source": "Phenotype_Arrhythmia",
          "target": "Disease_ARVC",
          "relation": "associated_with",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "心律失常是心脏病的一种常见表现"
        },
        {
          "source": "Phenotype_SV_Tachycardia",
          "target": "Disease_ARVC",
          "relation": "associated_with",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "超心速症常见于 心脏病患者"
        },
        {
          "source": "Phenotype_Ventricular_Tachycardia",
          "target": "Disease_ARVC",
          "relation": "associated_with",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "心室心动过速与心脏病相关性高"
        },
        {
          "source": "n_sotalol",
          "target": "n_ot_sotalol",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路作用产生不良效应"
        },
        {
          "source": "n_ot_sotalol",
          "target": "n_rp_sotalol",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可导致潜在风险通路"
        },
        {
          "source": "n_rp_sotalol",
          "target": "n_adv_sotalol",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路可能导致不良表型"
        },
        {
          "source": "n_adv_sotalol",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消 Sotalol 的净获益"
        }
      ],
      "round_index": 3
    },
    "history": {
      "round": 3,
      "last_scores": [
        {
          "hypothesis_id": "H1",
          "score": 0.68,
          "components": {
            "mechanism_fit": 0.75,
            "class_prior": 0.8,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.8,
            "safety_risk": 0.15,
            "graph_bonus": 0.2,
            "conflict_penalty": 0.1
          },
          "graph_signals": {
            "support_weight": 2.2,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "使用风险",
                "pro": [
                  "n_sotalol"
                ],
                "con": [
                  "n_adv_sotalol"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Sotalol 作为β-拮抗剂，其机制与心脏调节及心律失常改善预测相吻合"
            ],
            "safety_risk": [
              "Skeptic 指出 Sotalol 可能引发的不良反应与风险通路"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H2",
          "score": 0.55,
          "components": {
            "mechanism_fit": 0.7,
            "class_prior": 0.75,
            "pk_pd_feasibility": 0.65,
            "indication_plausibility": 0.7,
            "safety_risk": 0.2,
            "graph_bonus": 0.15,
            "conflict_penalty": 0.1
          },
          "graph_signals": {
            "support_weight": 1.9,
            "contradiction_weight": 0.8,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "使用风险",
                "pro": [
                  "n_amiodarone"
                ],
                "con": [
                  "n_adv_amiodarone"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Amiodarone 通过调节心脏电生理特性改善心率，其效用与心律失常相契合"
            ],
            "safety_risk": [
              "Skeptic 提到 Amiodarone 可能隐含的风险"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H3",
          "score": 0.62,
          "components": {
            "mechanism_fit": 0.8,
            "class_prior": 0.75,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.75,
            "safety_risk": 0.1,
            "graph_bonus": 0.15,
            "conflict_penalty": 0.1
          },
          "graph_signals": {
            "support_weight": 2.1,
            "contradiction_weight": 0.7,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "β-阻滞剂在降低心搏频率和控制心律上具有良好的基础，适合 ARVC 患者"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H4",
          "score": 0.58,
          "components": {
            "mechanism_fit": 0.75,
            "class_prior": 0.7,
            "pk_pd_feasibility": 0.65,
            "indication_plausibility": 0.7,
            "safety_risk": 0.15,
            "graph_bonus": 0.15,
            "conflict_penalty": 0.1
          },
          "graph_signals": {
            "support_weight": 1.8,
            "contradiction_weight": 0.75,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Dronedarone 的作用效果与心律失常治疗相关"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H5",
          "score": 0.52,
          "components": {
            "mechanism_fit": 0.7,
            "class_prior": 0.65,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.65,
            "safety_risk": 0.1,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.15
          },
          "graph_signals": {
            "support_weight": 1.5,
            "contradiction_weight": 0.5,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Verapamil 在影响心脏节律方面的作用与 ARVC 相关"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H6",
          "score": 0.5,
          "components": {
            "mechanism_fit": 0.65,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.6,
            "safety_risk": 0.1,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.1
          },
          "graph_signals": {
            "support_weight": 1.4,
            "contradiction_weight": 0.45,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Disopyramide 可用于改善心率问题"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H7",
          "score": 0.48,
          "components": {
            "mechanism_fit": 0.6,
            "class_prior": 0.55,
            "pk_pd_feasibility": 0.55,
            "indication_plausibility": 0.55,
            "safety_risk": 0.1,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.1
          },
          "graph_signals": {
            "support_weight": 1.3,
            "contradiction_weight": 0.4,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Flecainide 在某些心律失常中有效，但整体适应性较差"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H8",
          "score": 0.47,
          "components": {
            "mechanism_fit": 0.55,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.5,
            "safety_risk": 0.1,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.1
          },
          "graph_signals": {
            "support_weight": 1.2,
            "contradiction_weight": 0.35,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Procainamide 在控制心律方面有效，但存在较大道德风险"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H9",
          "score": 0.45,
          "components": {
            "mechanism_fit": 0.5,
            "class_prior": 0.45,
            "pk_pd_feasibility": 0.45,
            "indication_plausibility": 0.4,
            "safety_risk": 0.1,
            "graph_bonus": 0.05,
            "conflict_penalty": 0.15
          },
          "graph_signals": {
            "support_weight": 1.1,
            "contradiction_weight": 0.3,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Digoxin 对心脏收缩力存在一定影响，但应用于 ARVC 的证据较少"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H10",
          "score": 0.38,
          "components": {
            "mechanism_fit": 0.4,
            "class_prior": 0.35,
            "pk_pd_feasibility": 0.4,
            "indication_plausibility": 0.35,
            "safety_risk": 0.1,
            "graph_bonus": 0.05,
            "conflict_penalty": 0.15
          },
          "graph_signals": {
            "support_weight": 1.0,
            "contradiction_weight": 0.25,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Lisinopril 除心率外影响较小"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H11",
          "score": 0.35,
          "components": {
            "mechanism_fit": 0.3,
            "class_prior": 0.25,
            "pk_pd_feasibility": 0.3,
            "indication_plausibility": 0.3,
            "safety_risk": 0.1,
            "graph_bonus": 0.05,
            "conflict_penalty": 0.15
          },
          "graph_signals": {
            "support_weight": 0.9,
            "contradiction_weight": 0.2,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Spironolactone 主要用于辅助治疗，效果明显有限"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H12",
          "score": 0.3,
          "components": {
            "mechanism_fit": 0.2,
            "class_prior": 0.2,
            "pk_pd_feasibility": 0.2,
            "indication_plausibility": 0.2,
            "safety_risk": 0.1,
            "graph_bonus": 0.05,
            "conflict_penalty": 0.15
          },
          "graph_signals": {
            "support_weight": 0.7,
            "contradiction_weight": 0.15,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Hydrochlorothiazide 较少直接影响心律，使用效果不明显"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        }
      ]
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "revisions": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "drug_sotalol",
            "via": [
              "Target_Beta_adrenergic_receptor",
              "Pathway_Heart_regulation"
            ],
            "to": "Disease_ARVC",
            "success_criteria": "形成至少2条不相交路径",
            "assignee": "Proponent"
          },
          {
            "type": "stress_test_safety",
            "topic": "Sotalol 可能引起的不良反应",
            "expectation": "标注高权重 refutes 边以明确Sotalol的使用风险",
            "assignee": "Skeptic"
          }
        ],
        "debate_focus": [
          "更新Sotalol对ARVC的支持状况",
          "明确安全性方面的风险，并评估是否影响使用策略"
        ]
      }
    ],
    "pruned_hypotheses": [],
    "new_subhypotheses": [],
    "seed_request": {
      "should_regenerate": false,
      "reason": "当前假设间机制连通性良好，但安全性风险需明确评估，因此不需要再生种子。",
      "n": 4
    }
  }
}